By MOGOMOTSI MAGOME

JOHANNESBURG (AP) — Researchers and scientists in South Africa on Tuesday launched clinical trials on the first domestically developed vaccine.

Related Articles

The oral cholera vaccine, developed by the Cape Town-based pharmaceutical firm Biovac, is currently undergoing trials to determine its safety in adults and will be followed by trials to compare it to existing cholera vaccines that are already in the market.

Depending on the results, the vaccine could be approved and ready for use in Africa by 2028, Health Minister Aaron Motsoaledi said.

The development of the vaccine has been praised as a significant milestone for vaccine access in the country and across the rest of the continent.

Motsoaledi said that while South Africa experienced relatively low levels of

See Full Page